Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:HTLV-1
|
| gptkbp:affects |
adults
|
| gptkbp:associated_with |
immunosuppression
|
| gptkbp:caused_by |
gptkb:HTLV-1_virus
|
| gptkbp:clinical_trial |
gptkb:fandom
weight loss fever ongoing research night sweats thrombocytopenia elevated white blood cell count |
| gptkbp:complications |
infections
organ failure autoimmune disorders |
| gptkbp:first_described_by |
gptkb:1977
|
| gptkbp:genetic_diversity |
p53 mutation
Ras mutation |
| https://www.w3.org/2000/01/rdf-schema#label |
adult T-cell leukemia
|
| gptkbp:is_popular_in |
higher in certain regions
|
| gptkbp:related_to |
T-cell lymphotropic virus
|
| gptkbp:research_focus |
gptkb:vaccine
quality of life biomarkers health disparities clinical outcomes patient management long-term survival treatment resistance genetic profiling HTLV-1 transmission |
| gptkbp:risk_factor |
age
gender ethnicity |
| gptkbp:social_responsibility |
blood tests
poor cytogenetic analysis bone marrow biopsy immunophenotyping more common in Africa more common in Caribbean more common in Japan |
| gptkbp:symptoms |
fatigue
skin lesions hypercalcemia lymphadenopathy |
| gptkbp:treatment |
supportive care
radiation therapy chemotherapy targeted therapy stem cell transplant antiviral therapy |
| gptkbp:type |
gptkb:T-cell_neoplasm
|